Compounds > aripiprazole
Page last updated: 2024-08-24

aripiprazole and trihexyphenidyl

aripiprazole has been researched along with trihexyphenidyl in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Desarkar, P; Sinha, VK; Thakur, A1
Diberto, JF; Fish, EW; Krouse, MC; Malanga, CJ; Robinson, JE; Stringfield, SJ1
Asanome, A; Hasebe, N; Kano, K; Katayama, T; Saito, T; Sato, N; Sawada, J; Takahashi, K1

Reviews

1 review(s) available for aripiprazole and trihexyphenidyl

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

3 other study(ies) available for aripiprazole and trihexyphenidyl

ArticleYear
Aripiprazole-induced acute dystonia.
    The American journal of psychiatry, 2006, Volume: 163, Issue:6

    Topics: Acute Disease; Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dystonia; Humans; Male; Muscarinic Antagonists; Piperazines; Quinolones; Torticollis; Trihexyphenidyl

2006
Changes in sensitivity of reward and motor behavior to dopaminergic, glutamatergic, and cholinergic drugs in a mouse model of fragile X syndrome.
    PloS one, 2013, Volume: 8, Issue:10

    Topics: Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Blotting, Western; Cocaine; Disease Models, Animal; Dopamine Uptake Inhibitors; Excitatory Amino Acid Antagonists; Fragile X Mental Retardation Protein; Fragile X Syndrome; Immunoenzyme Techniques; Male; Mice; Mice, Knockout; Motor Activity; Muscarinic Antagonists; Piperazines; Pyridines; Quinolones; Receptor, Metabotropic Glutamate 5; Reward; Trihexyphenidyl; Tyrosine 3-Monooxygenase

2013
Combination therapy for segmental craniocervical dystonia (Meige syndrome) with aripiprazole, trihexyphenidyl, and botulinum toxin: three cases reports.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2015, Volume: 36, Issue:2

    Topics: Adult; Anti-Dyskinesia Agents; Aripiprazole; Botulinum Toxins; Drug Therapy, Combination; Female; Humans; Male; Meige Syndrome; Middle Aged; Treatment Outcome; Trihexyphenidyl

2015